Takara Bio Inc. (4974.T)
JPY 781.0
(0.0%)
JPY 781.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 25.45 Billion JPY | -43.13% |
| 2022 | 44.76 Billion JPY | -9.03% |
| 2021 | 49.21 Billion JPY | 54.4% |
| 2020 | 31.87 Billion JPY | 51.01% |
| 2019 | 21.1 Billion JPY | 2.03% |
| 2018 | 20.68 Billion JPY | 10.89% |
| 2017 | 18.65 Billion JPY | 10.04% |
| 2016 | 16.95 Billion JPY | 3.85% |
| 2015 | 16.32 Billion JPY | 18.06% |
| 2014 | 13.82 Billion JPY | 9.97% |
| 2013 | 12.57 Billion JPY | 14.06% |
| 2012 | 11.02 Billion JPY | 6.16% |
| 2011 | 10.38 Billion JPY | 5.11% |
| 2010 | 9.87 Billion JPY | -1.59% |
| 2009 | 10.03 Billion JPY | 1.0% |
| 2008 | 9.94 Billion JPY | -2.77% |
| 2007 | 10.22 Billion JPY | 4.08% |
| 2006 | 9.82 Billion JPY | 37.2% |
| 2005 | 7.15 Billion JPY | 12.42% |
| 2004 | 6.36 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 4.35 Billion JPY | -50.89% |
| 2023 Q4 | 8.86 Billion JPY | 88.72% |
| 2023 Q3 | 4.69 Billion JPY | -31.43% |
| 2023 Q2 | 6.85 Billion JPY | 5.51% |
| 2023 Q1 | 6.49 Billion JPY | -22.05% |
| 2023 FY | 25.45 Billion JPY | -43.13% |
| 2022 Q3 | 14.41 Billion JPY | 21.09% |
| 2022 FY | 44.76 Billion JPY | -9.03% |
| 2022 Q1 | 10.12 Billion JPY | -33.0% |
| 2022 Q2 | 11.9 Billion JPY | 17.53% |
| 2022 Q4 | 8.33 Billion JPY | -42.19% |
| 2021 Q2 | 10.35 Billion JPY | -21.18% |
| 2021 Q3 | 10.6 Billion JPY | 2.4% |
| 2021 FY | 49.21 Billion JPY | 54.4% |
| 2021 Q4 | 15.11 Billion JPY | 42.49% |
| 2021 Q1 | 13.13 Billion JPY | 23.72% |
| 2020 Q4 | 10.62 Billion JPY | 12.69% |
| 2020 Q2 | 7.12 Billion JPY | 51.45% |
| 2020 FY | 31.87 Billion JPY | 51.01% |
| 2020 Q1 | 4.7 Billion JPY | -25.51% |
| 2020 Q3 | 9.42 Billion JPY | 32.29% |
| 2019 FY | 21.1 Billion JPY | 2.03% |
| 2019 Q2 | 4.41 Billion JPY | -25.41% |
| 2019 Q1 | 5.91 Billion JPY | 2.98% |
| 2019 Q3 | 4.46 Billion JPY | 1.11% |
| 2019 Q4 | 6.31 Billion JPY | 41.53% |
| 2018 Q2 | 4.96 Billion JPY | -7.3% |
| 2018 Q4 | 5.74 Billion JPY | 24.35% |
| 2018 Q3 | 4.62 Billion JPY | -6.95% |
| 2018 Q1 | 5.35 Billion JPY | -9.04% |
| 2018 FY | 20.68 Billion JPY | 10.89% |
| 2017 Q3 | 4.6 Billion JPY | 13.7% |
| 2017 Q2 | 4.05 Billion JPY | -1.44% |
| 2017 Q1 | 4.11 Billion JPY | -6.89% |
| 2017 Q4 | 5.88 Billion JPY | 27.83% |
| 2017 FY | 18.65 Billion JPY | 10.04% |
| 2016 Q2 | 4.18 Billion JPY | 8.09% |
| 2016 Q3 | 4.49 Billion JPY | 7.46% |
| 2016 FY | 16.95 Billion JPY | 3.85% |
| 2016 Q4 | 4.41 Billion JPY | -1.74% |
| 2016 Q1 | 3.86 Billion JPY | -19.72% |
| 2015 Q2 | 4.03 Billion JPY | 21.34% |
| 2015 FY | 16.32 Billion JPY | 18.06% |
| 2015 Q4 | 4.81 Billion JPY | 15.96% |
| 2015 Q3 | 4.15 Billion JPY | 3.05% |
| 2015 Q1 | 3.32 Billion JPY | -24.03% |
| 2014 Q3 | 3.39 Billion JPY | 3.0% |
| 2014 Q4 | 4.37 Billion JPY | 28.66% |
| 2014 FY | 13.82 Billion JPY | 9.97% |
| 2014 Q1 | 2.75 Billion JPY | -29.49% |
| 2014 Q2 | 3.3 Billion JPY | 19.78% |
| 2013 Q3 | 3.06 Billion JPY | -10.2% |
| 2013 Q4 | 3.9 Billion JPY | 27.55% |
| 2013 FY | 12.57 Billion JPY | 14.06% |
| 2013 Q1 | 2.19 Billion JPY | -35.18% |
| 2013 Q2 | 3.41 Billion JPY | 55.54% |
| 2012 Q2 | 2.51 Billion JPY | -0.71% |
| 2012 Q4 | 3.38 Billion JPY | 30.67% |
| 2012 Q1 | 2.53 Billion JPY | -15.7% |
| 2012 FY | 11.02 Billion JPY | 6.16% |
| 2012 Q3 | 2.58 Billion JPY | 2.86% |
| 2011 Q3 | 2.6 Billion JPY | -0.8% |
| 2011 Q1 | 2.14 Billion JPY | -27.06% |
| 2011 Q4 | 3 Billion JPY | 15.3% |
| 2011 FY | 10.38 Billion JPY | 5.11% |
| 2011 Q2 | 2.62 Billion JPY | 22.85% |
| 2010 Q2 | 2.31 Billion JPY | 7.11% |
| 2010 FY | 9.87 Billion JPY | -1.59% |
| 2010 Q4 | 2.93 Billion JPY | 19.17% |
| 2010 Q3 | 2.46 Billion JPY | 6.17% |
| 2010 Q1 | 2.16 Billion JPY | -24.38% |
| 2009 Q2 | 2.52 Billion JPY | 22.76% |
| 2009 Q4 | 2.86 Billion JPY | 10.29% |
| 2009 Q3 | 2.59 Billion JPY | 2.85% |
| 2009 FY | 10.03 Billion JPY | 1.0% |
| 2009 Q1 | 2.05 Billion JPY | -27.17% |
| 2008 Q3 | 2.49 Billion JPY | 3.82% |
| 2008 Q2 | 2.4 Billion JPY | 0.0% |
| 2008 FY | 9.94 Billion JPY | -2.77% |
| 2008 Q4 | 2.82 Billion JPY | 12.97% |
| 2007 FY | 10.22 Billion JPY | 4.08% |
| 2006 FY | 9.82 Billion JPY | 37.2% |
| 2005 FY | 7.15 Billion JPY | 12.42% |
| 2004 FY | 6.36 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | -1253.163% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -31599.998% |
| GNI Group Ltd. | 22.43 Billion JPY | -13.489% |
| Linical Co., Ltd. | 3.77 Billion JPY | -573.771% |
| Trans Genic Inc. | 2.24 Billion JPY | -1031.792% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -25809.905% |
| Soiken Holdings Inc. | 2.48 Billion JPY | -925.511% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | -1869.425% |
| AnGes, Inc. | -3.06 Billion JPY | 930.493% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 14424.379% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | -163.421% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -4821.196% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -22843.329% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | -1654.934% |
| CanBas Co., Ltd. | -984 Million JPY | 2687.093% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -6399.14% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | -1437.12% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -6286.683% |
| Kidswell Bio Corporation | 1.03 Billion JPY | -2349.242% |
| PeptiDream Inc. | 17.21 Billion JPY | -47.845% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -83079.219% |
| Ribomic Inc. | -10.5 Million JPY | 242501.447% |
| SanBio Company Limited | -14.5 Million JPY | 175617.099% |
| Healios K.K. | 108 Million JPY | -23471.296% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 7465495.894% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 43213.843% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 1683764.021% |
| StemRIM | -44.34 Million JPY | 57501.52% |
| CellSource Co., Ltd. | 3.18 Billion JPY | -699.278% |
| FunPep Company Limited | -680.28 Million JPY | 3842.097% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -36661.011% |
| Stella Pharma Corporation | 217.29 Million JPY | -11615.248% |
| TMS Co., Ltd. | -6.95 Million JPY | 366387.77% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -7992.866% |
| Cuorips Inc. | 9.63 Million JPY | -264223.539% |
| K Pharma,Inc. | 910 Million JPY | -2697.473% |
| ReproCELL Incorporated | 1.1 Billion JPY | -2204.381% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | -2030.189% |
| StemCell Institute Inc. | 1.57 Billion JPY | -1515.413% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | -1427.312% |
| CellSeed Inc. | 107.15 Million JPY | -23657.174% |